Literature DB >> 30014349

Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?

Dimitri Patriki1, Andreas A Giannopoulos2.   

Abstract

Entities:  

Year:  2018        PMID: 30014349     DOI: 10.1007/s12350-018-1367-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

1.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).

Authors:  Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin G St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

Review 2.  New directions in cardiovascular risk assessment: the role of secondary risk stratification markers.

Authors:  A S Wierzbicki
Journal:  Int J Clin Pract       Date:  2012-07       Impact factor: 2.503

3.  Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose.

Authors:  Hugh Tunstall-Pedoe
Journal:  Heart       Date:  2011-03       Impact factor: 5.994

4.  Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.

Authors:  Kenichi Nakajima; Satoko Nakamura; Hiroki Hase; Yasuchika Takeishi; Shigeyuki Nishimura; Yuhei Kawano; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

6.  Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design.

Authors:  Hideo Kusuoka; Shigeyuki Nishimura; Akira Yamashina; Kenichi Nakajima; Tsunehiko Nishimura
Journal:  Ann Nucl Med       Date:  2006-04       Impact factor: 2.668

Review 7.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

Review 8.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Authors:  Marie Therese Cooney; Alexandra L Dudina; Ian M Graham
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 10.  Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging.

Authors:  S Iskander; A E Iskandrian
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  1 in total

1.  Seeing is believing: Visualization of multivariable risk models.

Authors:  Kenichi Nakajima; Hayato Tada
Journal:  J Nucl Cardiol       Date:  2022-09-12       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.